GLOW (50/5/5) from Adaptog Peptides is a research-grade blend combining 50mg GHK-Cu, 5mg BPC-157, and 5mg TB-500 in a single vial. This formulation is widely used in studies that examine skin-matrix biology, fibroblast activity, and connective-tissue research. Adaptog supplies GLOW at consistent purity so investigators can run reproducible protocols without preparing three separate reconstitutions.
The GLOW blend brings together three peptides commonly used in regenerative and dermatological research models. GHK-Cu is studied for its copper-binding activity and influence on extracellular matrix markers, while BPC-157 and TB-500 contribute well-documented profiles in cellular migration and repair-pathway research. Adaptog Peptides supplies GLOW (50/5/5) so laboratories can investigate the combined behaviour of these compounds under controlled conditions.
Researchers often buy GLOW (50/5/5) from Adaptog Peptides for projects such as:
Investigating fibroblast and keratinocyte responses in cultured models
Studying collagen and extracellular matrix marker expression
Examining angiogenic and migratory activity in tissue research
Comparing combined-peptide protocols to single-compound controls
Because GLOW pairs three well-characterised peptides at fixed ratios, it suits laboratories looking for efficient, repeatable workflows. Adaptog Peptides delivers GLOW (50/5/5) as a high-purity laboratory reagent prepared exclusively for qualified research environments. It is not intended for clinical, diagnostic, or therapeutic application.
For research use only. Not for human consumption.
The GLOW blend brings together three peptides commonly used in regenerative and dermatological research models. GHK-Cu is studied for its copper-binding activity and influence on extracellular matrix markers, while BPC-157 and TB-500 contribute well-documented profiles in cellular migration and repair-pathway research. Adaptog Peptides supplies GLOW (50/5/5) so laboratories can investigate the combined behaviour of these compounds under controlled conditions.
Researchers often buy GLOW (50/5/5) from Adaptog Peptides for projects such as:
Investigating fibroblast and keratinocyte responses in cultured models
Studying collagen and extracellular matrix marker expression
Examining angiogenic and migratory activity in tissue research
Comparing combined-peptide protocols to single-compound controls
Because GLOW pairs three well-characterised peptides at fixed ratios, it suits laboratories looking for efficient, repeatable workflows. Adaptog Peptides delivers GLOW (50/5/5) as a high-purity laboratory reagent prepared exclusively for qualified research environments. It is not intended for clinical, diagnostic, or therapeutic application.
For research use only. Not for human consumption.
| Type | Synthetic compound |
|---|---|
| Category | Research Compound |
| Purity | ≥99% |
| Form | Lyophilized powder |
-20°C · 24+ months
2–8°C · ~30 days
Third-party tested for purity and quality.
| Variant | GLP3-RT 10mg |
|---|---|
| Lot # | REF0001 |
| Labeled | 20mg |
| Actual | 22.61mg |
| Tested | APR 15, 2026 |
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Not a researcher? Exit
